Psychosomatic related disorders are diseases closely related to psychosocial factors. Patients are often treated in the non-psychiatric department of general hospitals due to somatic symptoms, and physicians often fail to recognize psychological symptoms, and could not make a proper diagnosis. Therefore, the status of diagnosis and treatment of psychosomatic disorders needs to be improved urgently. Wuling Capsule is a kind of national first class new traditional Chinese medicine with a single ingredient. It is widely used in the field of psychosomatic disorders. As an effective therapeutic drug for patients with depressive, anxious and insomnic symptoms in various departments of general hospitals, Wuling Capsule can be used alone or combined with other medications. It has fewer side effects and with higher safety. It can reduce patients′ stigma and, thus, increase compliance. All these make Wuling Capsule a valuable drug in clinical application. The aim of the consensus was to summarize the clinical application situation of Wuling Capsule in psychosomatic related disorders, standardize its application in clinical practice, and provide evidence-based expert consensus recommendations for the clinical diagnosis and treatment of psychosomatic related disorders for physicians in both general and primary hospitals.